Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Preliminary Evaluation of Uptake in Bone Metastases, Biodistribution and Excretion of the Novel Radiotracer [68Ga]P15-041 by PET/CT

NCT02826382 is registered in ClinicalTrials.gov with Five Eleven Pharma, Inc. as lead sponsor.

NCT NCT02826382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02826382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Preliminary Evaluation of Uptake in Bone Metastases, Biodistribution and Excretion of the Novel Radiotracer [68Ga]P15-041 by PET/CT
Lead sponsor
Five Eleven Pharma, Inc.
Phase
Phase 1
Overall status
Completed
Start date
September 20, 2016
Completion date
December 31, 2022
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, prostate cancer